BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 37631976)

  • 1. Effect of Pre-Treatment with a Recombinant Chicken Interleukin-17A on Vaccine Induced Immunity against a Very Virulent Marek's Disease Virus.
    Boodhoo N; Matsuyama-Kato A; Raj S; Fazel F; St-Denis M; Sharif S
    Viruses; 2023 Jul; 15(8):. PubMed ID: 37631976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon-γ influences immunity elicited by vaccines against very virulent Marek's disease virus.
    Haq K; Elawadli I; Parvizi P; Mallick AI; Behboudi S; Sharif S
    Antiviral Res; 2011 Jun; 90(3):218-26. PubMed ID: 21501630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of administration of probiotic lactobacilli on immunity conferred by the herpesvirus of turkeys vaccine against challenge with a very virulent Marek's disease virus in chickens.
    Bavananthasivam J; Alizadeh M; Astill J; Alqazlan N; Matsuyama-Kato A; Shojadoost B; Taha-Abdelaziz K; Sharif S
    Vaccine; 2021 Apr; 39(17):2424-2433. PubMed ID: 33781599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the Protection Efficacy of a Serotype 1 Marek's Disease Virus-Vectored Bivalent Vaccine Against Infectious Laryngotracheitis and Marek's Disease.
    Gimeno IM; Cortes AL; Faiz NM; Hernandez-Ortiz BA; Guy JS; Hunt HD; Silva RF
    Avian Dis; 2015 Jun; 59(2):255-62. PubMed ID: 26473676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of diluting Marek's disease vaccines on the outcomes of Marek's disease virus infection when challenged with highly virulent Marek's disease viruses.
    Gimeno IM; Cortes AL; Montiel ER; Lemiere S; Pandiri AK
    Avian Dis; 2011 Jun; 55(2):263-72. PubMed ID: 21793444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccinal Efficacy of Recombinant Marek's Disease Vaccine 301B/1 Expressing Chicken Interleukin-15.
    Kim T; Hearn C
    Avian Dis; 2022 Mar; 66(1):79-84. PubMed ID: 35191648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy of recombinant fowlpox vaccine protection against Marek's disease: its dependence on chicken line and B haplotype.
    Lee LF; Bacon LD; Yoshida S; Yanagida N; Zhang HM; Witter RL
    Avian Dis; 2004; 48(1):129-37. PubMed ID: 15077806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective efficacy of Marek's disease virus (MDV) CVI-988 CEF65 clone C against challenge infection with three very virulent MDV strains.
    de Boer GF; Groenendal JE; Boerrigter HM; Kok GL; Pol JM
    Avian Dis; 1986; 30(2):276-83. PubMed ID: 3015113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathotyping of Australian isolates of Marek's disease virus in commercial broiler chickens vaccinated with herpesvirus of turkeys (HVT) or bivalent (HVT/SB1) vaccine and association with viral load in the spleen and feather dander.
    Walkden-Brown SW; Islam A; Islam AF; Burgess SK; Groves PJ; Cooke J
    Aust Vet J; 2013 Aug; 91(8):341-50. PubMed ID: 23889101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A toll-like receptor 3 ligand enhances protective effects of vaccination against Marek's disease virus and hinders tumor development in chickens.
    Parvizi P; Mallick AI; Haq K; Haghighi HR; Orouji S; Thanthrige-Don N; St Paul M; Brisbin JT; Read LR; Behboudi S; Sharif S
    Viral Immunol; 2012 Oct; 25(5):394-401. PubMed ID: 22857262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant fowlpox virus vaccines against Australian virulent Marek's disease virus: gene sequence analysis and comparison of vaccine efficacy in specific pathogen free and production chickens.
    Heine HG; Foord AJ; Young PL; Hooper PT; Lehrbach PR; Boyle DB
    Virus Res; 1997 Jul; 50(1):23-33. PubMed ID: 9255932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccine-induced host responses against very virulent Marek's disease virus infection in the lungs of chickens.
    Haq K; Abdul-Careem MF; Shanmuganthan S; Thanthrige-Don N; Read LR; Sharif S
    Vaccine; 2010 Aug; 28(34):5565-72. PubMed ID: 20600510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection and synergism by recombinant fowl pox vaccines expressing genes from Marek's disease virus.
    Nazerian K; Witter RL; Lee LF; Yanagida N
    Avian Dis; 1996; 40(2):368-76. PubMed ID: 8790888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction of Recombinant HVT Expressing PmpD, and Immunological Evaluation against Chlamydia psittaci and Marek's Disease Virus.
    Liu S; Sun W; Chu J; Huang X; Wu Z; Yan M; Zhang Q; Zhao P; Igietseme JU; Black CM; He C; Li Y
    PLoS One; 2015; 10(4):e0124992. PubMed ID: 25893439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Load of challenge Marek's disease virus DNA in blood as a criterion for early diagnosis of Marek's disease tumors.
    Gimeno IM; Cortes AL; Silva RF
    Avian Dis; 2008 Jun; 52(2):203-8. PubMed ID: 18646447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of Marek's disease virus vaccines on chicken melanoma differentiation-associated gene 5-dependent-type I interferon signal transduction pathway with a highlight on their secondary impact on the immune responses post Newcastle disease virus vaccination.
    Hassanin O; Abdallah F; Mohamed MHA; Abdel Fattah DM
    Vet Microbiol; 2019 Aug; 235():248-256. PubMed ID: 31383309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early infection with Marek's disease virus can jeopardize protection conferred by laryngotracheitis vaccines: a method to study MDV-induced immunosuppression.
    Faiz NM; Cortes AL; Guy JS; Fletcher OJ; West M; Montiel E; Gimeno IM
    Avian Pathol; 2016 Dec; 45(6):606-615. PubMed ID: 27207594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of Recombinant Marek's Disease Virus Vaccine 301B/1 Expressing Membrane-Anchored Chicken Interleukin-15.
    Kim T; Hearn C; Heidari M
    Avian Dis; 2024 Jun; 68(2):117-128. PubMed ID: 38885053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Avirulent Marek's disease virus type 1 strain 814 vectored vaccine expressing avian influenza (AI) virus H5 haemagglutinin induced better protection than turkey herpesvirus vectored AI vaccine.
    Cui H; Gao H; Cui X; Zhao Y; Shi X; Li Q; Yan S; Gao M; Wang M; Liu C; Wang Y
    PLoS One; 2013; 8(1):e53340. PubMed ID: 23301062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptional Analyses of Innate and Acquired Immune Patterning Elicited by Marek's Disease Virus Vaccine Strains: Turkey Herpesvirus (HVT), Marek's Disease Virus 2 (strain SB1), and Bivalent Vaccines (HVT/SB1 and HVT-LT/SB1).
    Neerukonda SN; Katneni UK; Bhandari N; Parcells MS
    Avian Dis; 2019 Dec; 63(4):670-680. PubMed ID: 31865682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.